Showing posts with label biotech. Show all posts
Showing posts with label biotech. Show all posts

Thursday, 9 July 2020

Startup Funding Alert: Vor Biopharma Closes $110 Million Series B Financing


Vor Biopharma, an #oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced it has raised $110 million in a Series B financing.

Proceeds will advance the company’s lead candidate VOR33 into clinical trials, deepen its portfolio, and accelerate the validation of additional targets for its scientific platform, which is designed to remove redundant proteins so that transplanted stem cells become invisible to targeted therapies while leaving diseased cells vulnerable.

Vor’s treatment strategy has the potential to bring a revolutionary treatment paradigm for patients with acute myeloid leukemia and other hematologic malignancies.

Read on

Vor Biopharma Closes $110 Million Series B Financing " Vor Biopharma

Proceeds will advance the company's lead program into clinical trials and expand the portfolio CAMBRIDGE, Mass., - July 7, 2020 - Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced it has raised $110 million in a Series B financing.

Tuesday, 7 July 2020

The Chennai-based startup MicroGo's IoT-enabled hand hygiene device is seeing high demand amidst COVID-19


MicroGO, a Chennai-based biotech startup, has seen a rise in installations of its #IoT (Internet of Things) enabled hand hygiene device during the coronavirus pandemic. Founder Rachna Dave claims that it has installed around 180 units of its GOassure device since March 2, 2020, across various cities.

First installed at the Chennai airport, the GOassure was later added at other Airport Authority of India controlled airports in Baroda, Calicut, Hyderabad, Guwahati, Pune, and Kolkata, among others. The devices have also been installed at various enterprises like Taj Group, BigBasket, Tata Capital, etc.

Apart from GOassure, which is in heavy demand during COVID-19, MicroGO also manufactures devices like GOsteri, which can be used for sterilisation of surgical instruments and requires no water and electricity. It has also developed GOclean which is a disinfectant spray for surface disinfection and GOpure, for disinfection of domestic and sewage water. The startup also has its patented technology platform, Tubelet, which uses chlorine dioxide without contaminating the treated water with any chemical residues. Since its launch, MicroGO has filed seven patents and eight trademarks.

Read on

This Chennai-based startup's IoT-enabled hand hygiene device is seeing high demand amidst COVID-19

MicroGo, a Chennai-based biotech startup, has seen a rise in installations of its IoT (Internet of Things) enabled hand hygiene device during the coronavirus pandemic. Founder Rachna Dave claims that it has installed around 180 units of its GO assure device since March 2, 2020, across various cities.

Wednesday, 1 July 2020

Startup Funding Alert: French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative - Tech.eu


Owkin, a French company applying machine learning to medical research, has secured $18 million in funding from Mubadala Capital and Bpifrance, through the bank’s Large Venture fund. This Series A extension brings the startup’s total amount raised to $70 million.

The AI platform connects data scientists, clinicians, academic researchers and pharmaceutical companies to create global datasets and encourage collaborative research, all the while protecting patient data within a hospital’s local infrastructure. This ‘medical research ecosystem’ consists of four tools: Owkin Loop (the network), Owkin Connect (the technology infrastructure), Owkin Studio (the AI software tool) and Owkin Lab (the expertise).

Read on

French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative - Tech.eu

Owkin, a French company applying machine learning to medical research, has secured $18 million in funding from Mubadala Capital and Bpifrance, through the bank's Large Venture fund. This Series A extension brings the startup's total amount raised to $70 million. The AI platform connects data scientists, clinicians, academic researchers and pharmaceutical companies to create global ...

Tuesday, 30 June 2020

Covi-19: Bharat Biotech's Covid vaccine gets DCGI nod for clinical trials


Indian vaccine manufacturer Bharat Biotech has announced obtaining the approvals of the Drug Controller General of India to initiate phase-I and II human clinical trials for the vaccine candidate for Covid-19 it developed in collaboration with the National Institute of Virology, part of the Indian Council of Medical Research.

Read on

Bharat Biotech's Covid vaccine gets DCGI nod for clinical trials

Indian vaccine manufacturer Bharat Biotech has announced obtaining the approvals of the Drug Controller General of India to initiate phase-I and II human clinical trials for the vaccine candidate for Covid-19 it developed in collaboration with the National Institute of Virology, part of the Indian Council of Medical Research.